Zimmer Biomet Holdings, Inc. (ZBH)

NYSE: ZBH · Real-Time Price · USD
107.12
+1.31 (1.24%)
Dec 20, 2024, 4:00 PM EST - Market closed
1.24%
Market Cap 21.32B
Revenue (ttm) 7.60B
Net Income (ttm) 1.08B
Shares Out 199.04M
EPS (ttm) 5.26
PE Ratio 20.38
Forward PE 12.69
Dividend $0.96 (0.90%)
Ex-Dividend Date Sep 30, 2024
Volume 3,969,105
Open 105.34
Previous Close 105.81
Day's Range 105.34 - 107.76
52-Week Range 101.47 - 133.90
Beta 1.02
Analysts Hold
Price Target 123.68 (+15.46%)
Earnings Date Feb 6, 2025

About ZBH

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open hear... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1927
Employees 18,000
Stock Exchange NYSE
Ticker Symbol ZBH
Full Company Profile

Financial Performance

In 2023, Zimmer Biomet Holdings's revenue was $7.39 billion, an increase of 6.55% compared to the previous year's $6.94 billion. Earnings were $1.02 billion, an increase of 342.52%.

Financial Statements

Analyst Forecast

According to 21 analysts, the average rating for ZBH stock is "Hold." The 12-month stock price forecast is $123.68, which is an increase of 15.46% from the latest price.

Price Target
$123.68
(15.46% upside)
Analyst Consensus: Hold
Stock Forecasts

News

Zimmer Biomet to Present at the 43rd Annual J.P. Morgan Healthcare Conference

WARSAW, Ind. , Dec. 20, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will be presenting at the 43rd Annual J....

1 day ago - PRNewsWire

Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2024

WARSAW, Ind. , Dec. 18, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment ...

3 days ago - PRNewsWire

Zimmer Biomet Receives FDA Clearance for OsseoFit™ Stemless Shoulder System for Total Shoulder Replacement

New Anatomically Shaped Asymmetric Stemless Design for Total Shoulder Replacement WARSAW, Ind., Dec. 13, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technol...

8 days ago - PRNewsWire

Zimmer Biomet Receives FDA Clearance for Persona® SoluTion™ PPS® Femur

A Total Knee Replacement Alternative for Patients with Metal and/or Bone Cement Sensitivities WARSAW, Ind., Dec. 4, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medi...

17 days ago - PRNewsWire

Zimmer Biomet Receives FDA Approval for Oxford® Cementless Partial Knee, Only Cementless Partial Knee Replacement Implant in the U.S.

WARSAW, Ind., Nov. 25, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) Premarket Appr...

25 days ago - PRNewsWire

Zimmer Biomet to Present at Citi's 2024 Global Healthcare Conference

WARSAW, Ind. , Nov. 21, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will participate in the Citi Global Heal...

4 weeks ago - PRNewsWire

Zimmer Biomet Announces CE Mark Certification for Persona® Revision Knee System

WARSAW, Ind., and ZURICH , Nov. 18, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE: ZBH and SIX: ZBH), a global medical technology leader, today received the CE Mark for its Persona® Revision...

4 weeks ago - PRNewsWire

Arnold Schwarzenegger partners with Zimmer Biomet as chief movement officer

Arnold Schwarzenegger, former governor of California, and Ivan Tornos, president and CEO of Zimmer Biomet, join CNBC's 'Power Lunch' to discuss their partnership in promoting orthopedic health, how Zi...

5 weeks ago - CNBC Television

Zimmer Biomet Welcomes Arnold Schwarzenegger as Chief Movement Officer

Schwarzenegger to Inspire a Bold New Era of Well-being, Active Living and Reinvention to Advance Company's Mission to Alleviate Pain and Improve the Quality of Life for People Around the World WARSAW,...

5 weeks ago - PRNewsWire

Zimmer Biomet to Present at Jefferies London Healthcare Conference

WARSAW, Ind. , Nov. 7, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will participate in the Jefferies London ...

6 weeks ago - PRNewsWire

Orthopedic Implant Maker Zimmer Biomet Reports Better-Than-Expected Q3 Earnings, Updates Annual Forecasts

On Wednesday, Zimmer Biomet Holdings, Inc ZBH reported third-quarter adjusted EPS of $1.74, up from $1.65 a year ago, in line with the Street estimates.

7 weeks ago - Benzinga

Zimmer Biomet Holdings, Inc. (ZBH) Q3 2024 Earnings Call Transcript

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q3 2024 Earnings Conference Call October 30, 2024 8:30 AM ET Company Participants David DeMartino – Senior Vice President-Investor Relations Ivan Tornos – Pres...

7 weeks ago - Seeking Alpha

Implant maker Zimmer Biomet lowers full-year profit forecast

Hip implant maker Zimmer Biomet lowered its annual profit forecast on Wednesday following last month's disruptions to a software platform that was managing some of the company's operations.

7 weeks ago - Reuters

Zimmer Biomet Announces Third Quarter 2024 Financial Results

Third quarter net sales of $1.824 billion increased 4.0% and 4.1% on a constant currency1 basis Third quarter diluted earnings per share were $1.23; adjusted1 diluted earnings per share were $1.74 Com...

7 weeks ago - PRNewsWire

Zimmer Biomet to Debut New Z1™ Femoral Hip System and Clinical Data on G7® Acetabular System at 2024 AAHKS Annual Meeting

Company's Booth Spotlights Comprehensive Hip Portfolio and Enabling Technologies Including OrthoGrid Hip AI® and HAMMR™ Automated Hip Impaction System WARSAW, Ind. , Oct. 28, 2024 /PRNewswire/ -- Zimm...

7 weeks ago - PRNewsWire

Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2024 Financial Results

WARSAW, Ind. , Oct. 9, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its third quarter earnings conference call will be webcast on Wednesday, October 30, 2024 a...

2 months ago - PRNewsWire

Large Joint Devices Market Size, Share, and Global Trends Analysis 2024-2030: Zimmer Biomet Leads Global Hip Reconstruction Market with Taperloc and Arcos Systems

Dublin, Oct. 07, 2024 (GLOBE NEWSWIRE) -- The "Large Joint Devices Market Size, Share, and Trends Analysis Global 2024-2030 MedSuite Includes: Knee Replacement Market, Hip Replacement Market, and 1 mo...

2 months ago - GlobeNewsWire

Zimmer Biomet: The Undervalued Titan Of Joint Replacements

Zimmer Biomet, a leader in musculoskeletal health, excels in knee and hip replacements, and surgical robots, making it a sticky choice for many orthopedic surgeons. Competitive advantages include stro...

2 months ago - Seeking Alpha

Zimmer Biomet Stock Falls After the Medtech Firm Warns of Software Switch Impact

Shares of Zimmer Biomet Holdings (ZBH) dropped nearly 9% after the manufacturer of artificial joint replacements and other orthopedic products warned the implementation of a new enterprise resources p...

3 months ago - Investopedia

Zimmer Biomet Names David DeMartino as Senior Vice President, Investor Relations

WARSAW, Ind. , Sept. 5, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that David DeMartino will join the Company as Senior ...

3 months ago - PRNewsWire

Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2024

WARSAW, Ind. , Aug. 29, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment ...

4 months ago - PRNewsWire

Zimmer Biomet to Present at the Wells Fargo 2024 and Morgan Stanley Annual Global Healthcare Conferences

WARSAW, Ind. , Aug. 21, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team wil...

4 months ago - PRNewsWire

Zimmer Biomet beats profit estimates on strong demand for medical devices

Zimmer Biomet Holdings beat Wall Street estimates for second-quarter profit on Wednesday, driven by robust demand for its devices used in joint reconstruction procedures.

4 months ago - Reuters

Zimmer Biomet Signs Definitive Agreement to Acquire OrthoGrid Systems, Inc.

Acquisition Expands Hip Portfolio with Artificial Intelligence-Driven Surgical Guidance System WARSAW, Ind., Aug. 7, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global med...

4 months ago - PRNewsWire

10 Beaten-Up Blue Chips With Serious Turnaround Potential

Here is my list of blue-chip stocks to research for a buy-on-weakness strategy. Each has the potential to dip by -10% to -20%, given the July S&P 500 correction expands into a more serious bear market...

Other symbols: ABTCVSDVNHELEHSYIPGLW
5 months ago - Seeking Alpha